<DOC>
	<DOCNO>NCT01744366</DOCNO>
	<brief_summary>One month degarelix/comparator treatment prostate cancer Chinese population</brief_summary>
	<brief_title>One Month Degarelix/Comparator Treatment Prostate Cancer Chinese Population</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Chinese male 18 year Adenocarcinoma prostate Relevant disease status base lab value judge physician Life expectancy least year Previous hormonal treatment prostate cancer Considered candidate curative therapy Risk history serious significant health condition Has receive investigational drug within last 28 day previous treatment degarelix</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>